$0.9900
-0.12-10.81%
At close: -
$1.15
0.1616.16%
After Hours: Dec 19, 7:59 PM EDT
Comments
Loading...
Anebulo Pharmaceuticals (NASDAQ:ANEB) Stock, Earnings Estimates, EPS, And Revenue
Anebulo Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 11
EPS Estimate
$-0.080
Quarterly Revenue Estimate
–
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Anebulo Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
Anebulo Pharmaceuticals (ANEB) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-15 | $-0.06 | $-0.12 | 50.0 % |
| Dec 2023 | 2024-02-13 | $-0.11 | $-0.10 | -10.0 % |
| Sep 2023 | 2023-11-14 | $-0.10 | $-0.12 | 16.7 % |
| Jun 2023 | 2023-09-20 | $-0.10 | $-0.12 | 16.7 % |
Anebulo Pharmaceuticals (ANEB) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Anebulo Pharmaceuticals (NASDAQ:ANEB) reporting earnings?
Anebulo Pharmaceuticals (ANEB) is scheduled to report earnings on February 11, 2025. The last reported earnings were for reported on November 13, 2024 for Q1.
What were the latest earnings per share (EPS) for Anebulo Pharmaceuticals (NASDAQ:ANEB)?
The Actual EPS was $-0.08, which missed the estimate of $0.00.
What were Anebulo Pharmaceuticals’s (NASDAQ:ANEB) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.